LITAF regulation of cell death and inflammatory responses

LITAF 调节细胞死亡和炎症反应

基本信息

项目摘要

Project Summary Membrane damage by mechanical or biochemical stress, leads to cell death and activation of innate immune inflammatory pathways, and contributes to the pathology of many inflammatory conditions. Furthermore, pathogens can secrete pore-forming toxins (PFT) to promote infection and disrupt immunity, and endogenous pore-forming proteins such as Gasdermin D and MLKL have been shown to contribute to inflammatory signaling and secretion of cytokines. Cells have evolved multiple mechanisms to repair membrane damage and maintain cellular homeostasis, but our understanding of how damage is sensed and linked to repair remains incomplete. We have recently developed a transposon-based forward genetic screening approach, which we have used to identify genes that promote resistance to cell death induced by S. aureus α-toxin. We identified the lysosomal membrane protein LITAF as a cell-autonomous inhibitor of cell death. In preliminary data, we show that LITAF promotes sequestration of damaged membranes into vesicles through the activation of the ESCRT machinery. We hypothesize that LITAF acts as an effector of cellular defense against pore-forming proteins, linking sensing of membrane damage to effector mechanisms of repair. In this application, we propose to test this hypothesis by: (1) identifying the mechanisms of LITAF activation and function; (2) determining the role of this pathway in lung inflammation and infection; (3) testing whether LITAF regulates innate immune signaling, inflammasome activation and inflammatory cell death in macrophages. This research is of high significance as it will provide a deeper understanding of cellular defense mechanisms against membrane damage, and of the balance between cell survival and inflammatory cell death. Identifying strategies to counteract membrane damage and prevent cell death will contribute to understanding and treating the pathology of a wide range of infectious and inflammatory diseases.
项目摘要 机械或生化应力损害膜损伤,导致细胞死亡和先天免疫的激活 炎症途径,并导致许多炎症状况的病理。此外, 病原体可以秘密形成孔形成毒素(PFT),以促进感染和破坏免疫力,并内源性 孔形成蛋白(例如加油D和MLKL)已显示有助于炎症信号传导 和细胞因子的分泌。细胞已经发展了多种机制来修复膜损伤并维持 细胞体内稳态,但是我们对损害的感觉和与修复有关的理解仍然不完整。 我们最近开发了一种基于转座子的前向基因筛查方法,我们曾经用过这种方法 确定促进金黄色葡萄球菌α-毒素诱导的细胞死亡的基因。我们确定了溶酶体 膜蛋白LITAF是细胞自治的细胞死亡抑制剂。在初步数据中,我们证明了Litaf 通过激活ESCRT机械,将受损机制固定为蔬菜。 我们假设LITAF是针对形成孔的蛋白的细胞防御的效果,连接传感器 修复效应机制的膜损害。在此应用程序中,我们建议检验此假设 作者:(1)识别LITAF激活和功​​能的机制; (2)确定该途径在 肺部炎症和感染; (3)测试LITAF是否调节先天免疫信号,炎症 巨噬细胞中的激活和炎症细胞死亡。这项研究具有很高的意义,因为它将提供 对膜损伤的细胞防御机制的更深入了解,以及对 细胞存活和炎症细胞死亡。确定抵消膜破坏并防止的策略 细胞死亡将有助于理解和治疗广泛的感染性和 炎症性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adam Lacy-Hulbert其他文献

Adam Lacy-Hulbert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adam Lacy-Hulbert', 18)}}的其他基金

Immune Signatures and Clinical Outcomes in Acute Pancreatitis
急性胰腺炎的免疫特征和临床结果
  • 批准号:
    10568011
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
alpha v integrin regulation of B cell tolerance
B 细胞耐受的 α v 整合素调节
  • 批准号:
    10294130
  • 财政年份:
    2020
  • 资助金额:
    $ 29.96万
  • 项目类别:
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
使用转座子诱变鉴定流感宿主药物开发靶点
  • 批准号:
    8956296
  • 财政年份:
    2015
  • 资助金额:
    $ 29.96万
  • 项目类别:
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
使用转座子诱变鉴定流感宿主药物开发靶点
  • 批准号:
    9089858
  • 财政年份:
    2015
  • 资助金额:
    $ 29.96万
  • 项目类别:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
传染病宿主靶标和药物发现的转座子诱变
  • 批准号:
    8883359
  • 财政年份:
    2014
  • 资助金额:
    $ 29.96万
  • 项目类别:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
传染病宿主靶标和药物发现的转座子诱变
  • 批准号:
    8490300
  • 财政年份:
    2012
  • 资助金额:
    $ 29.96万
  • 项目类别:
Dendritic Cell Control of Intestinal T Cell Responses
树突状细胞控制肠道 T 细胞反应
  • 批准号:
    8868105
  • 财政年份:
    2012
  • 资助金额:
    $ 29.96万
  • 项目类别:
Dendritic Cell Control of Intestinal T Cell Responses
树突状细胞控制肠道 T 细胞反应
  • 批准号:
    8372489
  • 财政年份:
    2012
  • 资助金额:
    $ 29.96万
  • 项目类别:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
传染病宿主靶标和药物发现的转座子诱变
  • 批准号:
    8391403
  • 财政年份:
    2012
  • 资助金额:
    $ 29.96万
  • 项目类别:
Dendritic Cell Control of Intestinal T Cell Responses
树突状细胞控制肠道 T 细胞反应
  • 批准号:
    8843114
  • 财政年份:
    2012
  • 资助金额:
    $ 29.96万
  • 项目类别:

相似海外基金

Harnessing iron acquisition to hinder enterobacterial pathogenesis
利用铁的获取来阻碍肠细菌的发病机制
  • 批准号:
    10651432
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
利用分子技术改善资源有限环境中儿科急性呼吸系统疾病的诊断和管理
  • 批准号:
    10739603
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
Oklahoma Center for Respiratory and Infectious Diseases
俄克拉荷马州呼吸和传染病中心
  • 批准号:
    10628212
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
Cellular and microenvironmental mechanisms linking aging to tumor control
将衰老与肿瘤控制联系起来的细胞和微环境机制
  • 批准号:
    10348456
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
Microbiota, Probiotic and Dietary Metabolite Control of Enteric Pathogen Virulence
微生物群、益生菌和膳食代谢物对肠道病原体毒力的控制
  • 批准号:
    10562497
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了